Evidence mapPaperPMID 33777611Full record

ArticleDiabetology international2021

Diabetes-related acute metabolic emergencies in COVID-19 patients: a systematic review and meta-analysis.

Vasileios P Papadopoulos, Marios-Vasileios Koutroulos, Dimitra-Georgia Zikoudi, Stefania-Aspasia Bakola, Peny Avramidou, Ntilara Touzlatzi, Dimitrios K Filippou

Open access · bronzeAbstract read
In one paragraph

Article in Diabetology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vasileios P PapadopoulosDepartment of Internal Medicine, Xanthi General Hospital, Xanthi, Greece.ORCID 0000-0002-4188-9518
Marios-Vasileios KoutroulosDepartment of Internal Medicine, Xanthi General Hospital, Xanthi, Greece.
Dimitra-Georgia ZikoudiDepartment of Internal Medicine, Xanthi General Hospital, Xanthi, Greece.
Stefania-Aspasia BakolaDepartment of Internal Medicine, Xanthi General Hospital, Xanthi, Greece.
Peny AvramidouDepartment of Internal Medicine, Xanthi General Hospital, Xanthi, Greece.
Ntilara TouzlatziDepartment of Internal Medicine, Xanthi General Hospital, Xanthi, Greece.
Dimitrios K FilippouDepartment of Anatomy and Surgical Anatomy, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Democritus University of Thrace · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsCOVID-19 is associated with diabetic ketoacidosis (DKA), hyperglycaemic hyperosmolar state (HHS) and euglycaemic DKA (EDKA); however, evidence regarding parameters affecting outcome and mortality rates is scarce.

methodsA systematic literature review was conducted using EMBASE, PubMed/Medline, and Google Scholar from January 2020 to 7 January 2021 to identify all studies describing clinical profile, outcome and mortality rates regarding DKA, HHS, DKA/HHS and EDKA cases in COVID-19 patients. The appropriate Joanna Briggs Institute tools were used for quality assessment; quality of evidence was approached using GRADE. Univariate and multivariate analyses were used to assess correlations between clinical characteristics and outcome based on case reports. Combined mortality rates (CMR) were estimated from data reported in case report series, cross-sectional studies, and meta-analyses. The protocol was submitted to PROSPERO (ID: 229356/230737).

resultsFrom 312 identified publications, 44 were qualitatively and quantitatively analyzed. Critical COVID-19 necessitating ICU (

conclusionAcute diabetes-related metabolic emergencies in COVID-19 patients lead to increased mortality; key determinants are critical COVID-19 illness, coexistence of DKA/HHS and AKI. Previous SGLT-2i treatment, though associated with EDKA, might preserve renal function in COVID-19 patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13340-021-00502-9.

Indexed as

Acute kidney injuryCOVID-19Diabetes complicationsDiabetic ketoacidosisEuglycaemic diabetic ketoacidosisHyperosmolar hyperglycemic state

Identifiers

PMID33777611
PMCPMC7985576
OpenAlexW3139333180

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.